AngioSlide

company

About

Angioslide is a medical device company that develops Embolic Capture Angioplasty device.

  • 11 - 50

Details

Last Funding Type
Series D
Last Funding Money Raised
$6.30M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$30.15M
AngioSlide has raised a total of $30.15M in funding over 2 rounds. Their latest funding was raised on May 1, 2015 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 1, 2015 Series E $3M 2 Detail
Jan 3, 2013 Series D $6.30M 2 Triventures Detail
Aug 1, 2009 Series C $8.25M 1 Detail
May 1, 2008 Series B $8.60M 1 Detail
Dec 1, 2006 Series A $4M 1 Viola Partners Detail

Investors

Number of Lead Investors
Number of Investors
2
2
AngioSlide is funded by 2 investors. Viola Partners and Triventures are the most recent investors.
Investor Name Lead Investor Funding Round
Viola Partners Series E
Triventures Series E